Difference Between BCG and DPT Vaccine

Difference between topics can clarify health conditions, treatments, and insurance terms that often confuse readers. ManipalCigna's guides compare key points clearly, supporting informed healthcare choices.


These guides highlight important differences simply, helping readers understand options before choosing suitable healthcare or insurance solutions.

Cashless treatment at top hospitals

Quick & easy claims

High coverage up to ₹3 crore

Award winning products

5% Discount on Website Purchase*
* Terms & Conditions applied according to company policy

Get Your Health Insurance Quote Instantly!

I have read and agree to the .
X

Enter the OTP sent to your registered mobile number for verification.

Enter OTP

Please enter a valid OTP

Difference between BCG Vaccine and DPT Vaccine is a concise, reader-friendly overview of how these vaccines differ in purpose, schedule, and safety considerations, helping Indian readers understand which may be relevant to their child's immunisation plan. Consult your insurer, including ManipalCigna Health Insurance, for policy-specific guidance.

BCG Vaccine vs DPT Vaccine - Comparison Table

Basis BCG Vaccine DPT Vaccine
Vaccine type BCG is a live attenuated vaccine DPT is a toxoid-based, inactivated combination vaccine
Route of administration Intradermal (intracutaneous) at the upper arm Intramuscular (IM) injection in thigh or upper arm
Initial age for first dose At birth or within the first month First dose around 6 weeks of age
Dosing schedule (primary series) Typically a single dose Three primary doses (6, 10, 14 weeks) per schedule
Booster doses No routine booster in standard schedules Booster doses recommended in some schedules later in childhood
Target disease Prevention of severe TB forms in children Prevention of diphtheria, pertussis, and tetanus
Protection duration Protection varies; may wane; TB protection is for severe forms Protection wanes over time; boosters extend immunity
Common side effects Local site reaction; swelling; rarely lymphadenitis Pain at injection site; fever; irritability; rare serious reactions
Contraindications Immunocompromised status or active TB suspicion Severe allergic reactions; history of encephalopathy after previous dose
Storage Refrigerated; reconstitution as per product Refrigerated; cold chain required
Vaccine type detail Live attenuated Mycobacterium bovis Diphtheria, tetanus toxoids with inactivated pertussis component
Administration site Upper arm deltoid region (intracutaneous) Thigh or deltoid muscle (intramuscular)
Doses per vial Often single-dose vials Commonly multi-dose vials
Needle size Small intradermal needle; shallow injection Standard intramuscular needle size
Co-administration with other vaccines Can be given with other vaccines per schedule Usually given with other infant vaccines in the routine schedule
Reaction monitoring Monitor for local ulcers and lymphadenitis Watch for fever and injection-site reactions; rare adverse events
Public health role Part of TB control in high-burden settings Essential component of routine immunisation programs for DPT
Global availability Widely used in TB-endemic regions Widely used globally as part of immunisation programs
Cost considerations Often lower per-dose due to single-dose approach Cost varies by region and program; multi-dose logistics influence cost
TB testing impact BCG may cause a false-positive tuberculin skin test in some cases DPT does not affect TB skin test results
Schedule integration Typically given at birth within the immunisation schedule Given as part of routine infant immunisations starting at 6 weeks
WHO position WHO endorses BCG in TB-endemic areas WHO recommends DPT as a core immunisation component
Administration training Intracutaneous technique requires specific training Intramuscular technique requires proper dosing training
Common myths BCG does not guarantee complete TB protection DPT does not cause autism; vaccines do not cause autism
Vaccine acceptance Acceptance linked to TB risk perception and safety Acceptance linked to disease severity and vaccine safety perceptions
Scar formation BCG may leave a small scar DPT typically leaves no lasting scar
Pregnancy considerations Not given during pregnancy; plan after delivery Pregnant women are generally advised to defer DPT; guidance varies
Immunity testing effects BCG can influence tuberculin skin test results to some extent DPT does not influence TB testing
Programmatic role Supports TB prevention in national programs Supports prevention of diphtheria, pertussis and tetanus in national programs
Storage requirements Reconstitution may be required before use Typically provided as ready-to-use liquid in vials

What is BCG Vaccine?

DPT Vaccine is a combination immunisation that protects against diphtheria, pertussis, and tetanus. It uses inactivated components to stimulate immunity without causing disease, and forms a core part of many childhood vaccination schedules worldwide.

In practice, BCG is administered intradermally, usually on the upper arm. Its effectiveness varies by region and population, and coverage depends on policy and supply. Always consult a qualified healthcare professional for guidance on eligibility and timing as per local guidelines.

Advantages of BCG Vaccine

  • May reduce risk of severe TB forms in children
  • Single-dose birth dose where applicable
  • Intracutaneous administration uses small amounts
  • Well-established in India
  • Can be given with other vaccines in routine schedules
  • Supports TB control in endemic settings
  • Longstanding public health experience
  • Local reactions are usually manageable
  • Does not require complex infrastructure
  • Logistically simple to implement in primary care
  • Included in many national immunisation programs
  • Often cost-effective per child in single-dose programs
  • Stable under standard refrigerated storage
  • Has a long track record of safety monitoring
  • Healthcare workers receive defined intradermal technique training
  • Can be adapted to different program formats
  • Public health agencies routinely audit coverage
  • Doses are typically well tolerated in infants
  • Guidance exists on co-administration with other vaccines

Disadvantages of BCG Vaccine

  • Protection against pulmonary TB is variable
  • Not guaranteed to prevent all TB forms
  • May cause local ulceration or lymphadenitis
  • Rare serious adverse events can occur
  • Protection may wane over time without boosters in most policies
  • Cannot provide complete TB protection for all ages
  • Requires cold-chain storage and reliable supply
  • Administered intradermally, requiring trained staff
  • Not suitable for all immunocompromised individuals
  • In some settings, BCG-related scars may be stigmatizing
  • Not designed to protect against non-TB diseases
  • Effectiveness can vary by geography and strain
  • May cause scar formation in a subset of recipients
  • Vaccination may be postponed during illness
  • Misinformation can affect uptake
  • Some regions experience vaccine supply interruptions
  • Administration requires coordination with other vaccines
  • Not a standalone solution for TB control
  • Monitoring for adverse events relies on healthcare access

What is DPT Vaccine?

DPT Vaccine is a combination immunisation that protects against diphtheria, pertussis, and tetanus. It uses inactivated components to stimulate immunity without causing disease, and forms a core part of many childhood vaccination schedules worldwide.

Practically, DPT is given in multiple doses during the first months of life, alongside other vaccines in the universal immunisation program. It aims to build stage-wise immunity and reduce disease burden; please consult a healthcare professional for policy-specific guidance.

Advantages of DPT Vaccine

  • Protects against three major diseases with one shot
  • Well-established in national immunisation programs
  • Can be given with other routine vaccines
  • Boosters extend protection over time
  • Part of standard infant vaccination schedule
  • Supports herd immunity when coverage is high
  • Inactivated components reduce infection risk
  • Widely accepted due to safety monitoring
  • Clear international guidelines for schedule timing
  • Administered intramuscularly by trained staff
  • Especially effective against severe disease forms in children
  • Stable in regular vaccine cold chains
  • Cost-effective when delivered through programs
  • Involves straightforward storage requirements
  • Public health agencies track coverage and outcomes
  • Can be integrated with other health visits
  • Flexibility in timing within recommended windows
  • Has contributed to declines in diphtheria and tetanus
  • Encourages maternal and caregiver engagement in immunisation
  • Education materials support informed decision-making

Disadvantages of DPT Vaccine

  • Booster dependence for long-term protection
  • Non-specific protection improves but is not perfect
  • Mild fever or injection-site reactions can occur
  • Very rare neurologic reactions have been reported
  • Cannot prevent all forms of pertussis
  • May cause irritability or poor feeding temporarily
  • Contraindications limit use in some infants
  • Not suitable for those with severe allergies to components
  • Vaccination timing can be impacted by illnesses
  • Vaccine hesitancy can reduce uptake
  • Needle injections may cause distress in infants
  • Cold-chain disruptions can affect potency
  • Misconceptions about vaccines can affect acceptance
  • Some parents worry about cumulative injections
  • Documentation and record-keeping required for boosters
  • Supply chain issues can impact availability
  • Post-vaccination reactions require observation
  • Not a guaranteed shield against all exposure risks
  • The schedule may differ across regions
  • Real-world effectiveness depends on coverage rates

Similarities Between BCG Vaccine and DPT Vaccine

Common Aspect Explanation

Conclusion on Difference Between BCG and DPT Vaccine

BCG and DPT vaccines address different disease risks and follow distinct schedules. The key difference lies in their targets, administration route, and timing, which informs a child's immunisation plan and may influence coverage considerations within policy terms.

To proceed, discuss your child's vaccination needs with a qualified healthcare professional and review policy terms with your insurer. Vaccine coverage is subject to policy terms, exclusions and waiting periods.

FAQs on Difference Between BCG and DPT Vaccine

What is the main purpose of the BCG vaccine?

BCG mainly aims to reduce the risk of severe tuberculosis forms in children; consult a doctor for local guidance.

What diseases does the DPT vaccine protect against?

DPT protects against diphtheria, pertussis and tetanus, as per national immunisation guidelines.

When is the BCG vaccine usually given?

In many settings, it is given at birth or within the first month of life.

When should the first DPT dose be given?

The first DPT dose is typically given around 6 weeks of age, with subsequent doses per schedule.

Are there common side effects after these vaccines?

Common reactions include local site effects, fever or irritability; seek care for any severe or persistent symptoms.

Can I receive these vaccines if I am pregnant?

BCG is generally not given during pregnancy; DPT timing may be adjusted per guidelines; consult a clinician.

Do these vaccines interact with insurance policies?

Vaccination costs may be covered subject to policy terms, waiting periods, and exclusions.

Is one vaccine safer than the other?

Both vaccines have safety profiles, but risks vary by individual health and contraindications; consult a doctor.

Can these vaccines be given with other vaccines at the same visit?

In many cases, yes, but scheduling follows local guidelines and physician advice.

Does BCG protect against all TB forms for life?

BCG does not guarantee complete protection against all TB forms; protection varies by disease and geography.

Disclaimer: The information provided on this page regarding the difference between BCG Vaccine and DPT Vaccine is for general informational and awareness purposes only. It does not constitute medical advice, diagnosis, treatment recommendation, financial advice or insurance advice of any kind. Readers are strongly advised to consult qualified healthcare professionals for medical guidance and licensed insurance advisors for insurance-related decisions. ManipalCigna Health Insurance does not guarantee, endorse or validate any specific medical condition, treatment, procedure, hospital, doctor or insurance product mentioned on this page. Insurance coverage for any medical condition or procedure is subject to the specific terms, conditions, exclusions, waiting periods and limitations of the respective health insurance policy. Policyholders and prospective buyers are advised to read the policy wording and sales brochure carefully before concluding a sale.